Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-23-059844
Filing Date
2023-05-12
Accepted
2023-05-12 17:01:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2315630-1_424b5.htm 424B5 514749
2 GRAPHIC lg_carismatherapeutics-4c.jpg GRAPHIC 58482
  Complete submission text file 0001104659-23-059844.txt   596630
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-271295 | Film No.: 23916842
SIC: 2834 Pharmaceutical Preparations